Category: benralizumab

  • AstraZenca Reports Results of Fasenra (benralizumab) in P-lllb PONENTE Trial for Asthma

    Shots: It is based on P-lllb PONENTE trial assessing Fasenra (benralizumab, 30mg) in adult patients with severe Asthma on high-dose ICS + LABA and long-term use of OCS therapy with or without additional asthma controller. This study included approx. 600 patients in EU, North America, South America, and Taiwan Results: 62% of patients achieved complete […]